Jefferies Assumes Amphastar Pharmaceuticals (AMPH) at Buy
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.13 +0.75%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Jefferies analyst Glen Santangelo assumes coverage on Amphastar Pharmaceuticals (NASDAQ: AMPH) with a Buy rating and a price target of $36.00.
For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.
Shares of Amphastar Pharmaceuticals closed at $29.23 yesterday.
You May Also Be Interested In
- Lake Street Starts RF Industries Ltd. (RFIL) at Buy
- Alliance Global Partners Starts Momentus (MNTS) at Buy
- Raymond James Starts Polaryx Therapeutics (PLYX) at Strong Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
